Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

388.95
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
340.09
Today|||52-Week Range
543.55
+5.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues1.2B1.3B1.5B1.5B
 
 
 
 
 
Cost of Goods Sold74.7M84.2M102.9M104.2M
 
 
 
 
 
Depreciation And Amortization28.9M38.1M35.1M37.7M
 
 
 
 
 
 
Operating ExpensesGross Income1.1B1.2B1.3B1.4B
 
 
 
 
 
General Expenses776.2M766.2M781.8M798.8M
 
 
 
 
 
Research And Development450.3M469.3M474.8M492.0M
 
 
 
 
 
Total Operating Expenses879.8M888.4M919.8M940.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income347.0M430.5M550.3M559.9M
 
 
 
 
 
Extraordinary Charge--0.00-30.1M0.00
 
 
Interest Expense On Debt--7.5M5.4M6.2M
 
 
 
 
Other Expenses-5.5M9.2M11.0M11.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income341.5M432.3M525.9M565.6M
 
 
 
 
 
Income Taxes-88.4M-183.4M-138.1M-177.3M
 
 
 
 
 
Net Income253.1M248.9M387.7M388.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS105.1M105.6M106.0M106.7M
 
 
 
 
 
Shares To Calculate EPS Diluted115.8M115.1M116.1M117.0M
 
 
 
 
 
 
Earnings Per ShareEPS$2.19$2.16$3.34$3.32
 
 
 
 
 
EPS Diluted$2.19$2.16$3.34$3.32